Compliance with follow-up in patients with diabetic macular edema: Eye care center vs. diabetes care center

Simple item page
dc.contributor.authorKumar, Geethaen_US
dc.contributor.authorVelu, Saranyaen_US
dc.contributor.authorRajalakshmi, Ramachandranen_US
dc.contributor.authorSurya, Jananien_US
dc.contributor.authorMohan, Viswanathanen_US
dc.contributor.authorRaman, Aayushien_US
dc.contributor.authorRaman, Rajiven_US
dc.date.accessioned2023-08-25T06:37:26Z
dc.date.available2023-08-25T06:37:26Z
dc.date.issued2023-06
dc.description.abstractPurpose: The study was conducted to compare the compliance to intravitreal injection treatment and follow?up in patients with center?involving diabetic macular edema (CI?DME) and treatment outcomes between a tertiary eye care facility and a tertiary diabetes care center. Methods: A retrospective review was conducted on treatment naïve DME patients who had received intravitreal anti?vascular endothelial growth factor (anti?VEGF) injections in 2019. Participants were people with type 2 diabetes who were under regular care at the eye care center or the diabetes care center in Chennai. The outcome measures were noted at months 1, 2, 3, 6, and 12. Results: A review of 136 patients treated for CI?DME (72 from the eye care center and 64 from a diabetes care center) was carried out. The severity of diabetic retinopathy (DR) was similar in both centers. There was no statistically significant (P > 0.05) difference in the choice of initial intravitreal drug in the two centers. At 12?month follow?up, only 29.16% came for a follow?up in the eye center vs. 76.56% in a diabetes care center (P = 0.000). The multivariate logistic regression showed increasing age was associated with non?compliance in both the groups (eye care center: odds ratio [OR] 0.91; 95% confidence interval [CI] 0.82–1.21; P = 0.044) and diabetes care center (OR 1.15; 95% CI 1.02–1.29; P = 0.020). Conclusion: The follow?up rate between eye care and diabetic care center with DME showed a significant disparity. By providing comprehensive diabetes care for all complications under one roof, compliance with follow?up can be improved in people with DMEen_US
dc.identifier.affiliationsDepartment of Ophthalmology, Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, Indiaen_US
dc.identifier.affiliationsDepartment of Ophthalmology, Dr. Mohan’s Diabetes Specialities Centre and Madras Diabetes Research Foundation, Chennai, Tamil Nadu, Indiaen_US
dc.identifier.affiliationsDepartment of Diabetology, Dr. Mohan’s Diabetes Specialities Centre and Madras Diabetes Research Foundation, Chennai, Tamil Nadu, Indiaen_US
dc.identifier.affiliationsPadma Seshadri Bala Bhavan Senior Secondary School, Chennai, Tamil Nadu, Indiaen_US
dc.identifier.citationKumar Geetha, Velu Saranya, Rajalakshmi Ramachandran, Surya Janani, Mohan Viswanathan, Raman Aayushi, Raman Rajiv. Compliance with follow-up in patients with diabetic macular edema: Eye care center vs. diabetes care center. Indian Journal of Ophthalmology. 2023 Jun; 71(6): 2531-2536en_US
dc.identifier.issn1998-3689
dc.identifier.issn0301-4738
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/225093
dc.languageenen_US
dc.publisherAll India Ophthalmological Societyen_US
dc.relation.issuenumber6en_US
dc.relation.volume71en_US
dc.source.urihttps://doi.org/10.4103/IJO.IJO_220_23en_US
dc.subjectComplianceen_US
dc.subjectdiabetes care centeren_US
dc.subjecteye care centeren_US
dc.subjectdiabetic macular edemaen_US
dc.subjectintravitreal injectionsen_US
dc.titleCompliance with follow-up in patients with diabetic macular edema: Eye care center vs. diabetes care centeren_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJO2023v71n6p2531.pdf
Size:
1.88 MB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Ophthalmology